Acute Renal Failure Clinical Trial
Official title:
Does the Inferior Vena Cava Size Assessment Help in the Management of Acute Kidney Injury in Critically Ill Patients?
Bedside ultrasonographic assessment of IVC size and IVC collapsibility index can be used to guide the management of patients with acute kidney injury with and without volume overload in the intensive care unit
Consecutive patients presenting to the intensive care unit with a diagnosis of acute renal
failure (defined as a 1.5 fold increase in plasma Creatinine level compared to baseline ).
Baseline characteristics will be recorded and followed for each patient, these include:
1. Demographics
2. Medical history
3. Hemodynamic parameter such as Central Venous Pressure (CVP), Mean Arterial Pressure
(MAP) , and measurement of superior vena cava (SVC) size by ultrasound.
4. Laboratory parameter such as chemistry, fractional excretion of sodium , fractional
excretion of urea , beta natriuretic peptide , albumin
5. Radiographic parameters
6. Echocardiographic parameters including Left Ventricular Ejection Fraction (LVEF), Right
Ventricular (RV) function and IVC size and variations
7. Mechanical ventilation
8. Daily fluid balance
Focused bedside ultrasound will be performed for each patient as part of their routine care
and initial assessment. The IVC size will be measured at the subcostal window, during
inspiration and expiration, using the (Sonosite) Cardiac probe P-21 (5-1 MHZ). The
measurement is obtained by applying the M-mode, perpendicular to the IVC axis and 2 cm
caudal from its junction with the right atrium.
In spontaneously breathing, non-ventilated patients, we will calculate the IVC
collapsibility index (IVC-CI) = [IVC max-IVC min]/IVC max.
Whereas in patients who are mechanically ventilated we will calculate their IVC variation
index (ΔIVC) = IVC max-IVC min/ IVC mean diameter.
IVC-CI, ΔIVC, IVC size will be used to classify patient as volume responders or
non-responder. Prior studies have suggested Intravascular volume depletion is likely present
when the, IVC<1 cm , IVC-CI is > 50% in spontaneously breathing patients and volume
responsiveness when the ΔIVC is ≥ 12% in mechanically ventilated patient .
The Fractional excretion of sodium as well as the fractional excretion of urea (when
diuretics are used) will be calculated to classify the etiology of the renal failure as
pre-renal or intrinsic renal failure.
Fluid balance as well as the change in plasma Creatinine level at 48 hours post admission
will be recorded.
Two groups of patients will be identified:
- Group 1 includes the patients who were managed in concordance with their IVC
measurements (Volume responders who had a positive fluid balance at 48 h post admission
and volume non responders who had an even or negative fluid balance at 48 hours post
admission).
- Group 2 includes the patients in whom the fluid management was discordant with the IVC
measurement.
Analyses will be done at 24 as well as 48 hours post admission.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01946113 -
Mineral-Homeostasis in Continuous Renal Replacement Therapy
|
N/A | |
Withdrawn |
NCT00993733 -
Assessing the Impact of Two Methods of Continuous Veno-venous Hemodiafiltration on Time Nursing Work in Intensive Care
|
N/A | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Terminated |
NCT00978354 -
Furosemide in Early Acute Kidney Injury
|
Phase 2/Phase 3 | |
Completed |
NCT00120263 -
Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
|
N/A | |
Completed |
NCT04799600 -
The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU
|
||
Recruiting |
NCT04334707 -
Kidney Precision Medicine Project
|
||
Completed |
NCT02858531 -
Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics
|
||
Recruiting |
NCT05282732 -
Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients
|
||
Completed |
NCT01467466 -
Prevention of Serious Adverse Events Following Angiography
|
Phase 3 | |
Completed |
NCT01979042 -
Urinary Markers for Unilateral Kidney Obstruction
|
N/A | |
Completed |
NCT01280617 -
Low Dose Thymoglobin in Renal Transplant Patients
|
N/A | |
Completed |
NCT00780351 -
Dosing Vancomycin in Patients on Sustained Low Efficiency Daily Hemodiafiltration (SLEDD-f)
|
N/A | |
Completed |
NCT00971971 -
Prevention of Intradialytic Hypotension in Acute Kidney Injury Patients
|
N/A | |
Completed |
NCT00076219 -
Acute Renal Failure Trial Network (ATN) Study
|
Phase 3 | |
Recruiting |
NCT04599569 -
Influence of Renal Replacement TherApy on Indirect Calorimetry
|
||
Completed |
NCT03727204 -
Acute Kidney Injury After Cardiac Surgery: Novel Ultrasound Techniques for Prediction of Acute Kidney Injury
|
||
Completed |
NCT06005896 -
A Clinical Model for Dialysis Discontinuation in AKI
|
||
Completed |
NCT03627884 -
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
|
Phase 4 | |
Completed |
NCT03004950 -
Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)
|